Immunomodulation of Islet Organoids and the Promise of Sustainable Beta Cell Replacement: Has the Challenge Been Met?
- 22 February 2021
- journal article
- editorial
- Published by Wolters Kluwer Health in Transplantation
- Vol. 105 (3) , 466-467
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Immune-evasive human islet-like organoids ameliorate diabetesNature, 2020
- Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 DiabetesFrontiers in Endocrinology, 2020
- The Future of Islet Transplantation Is NowFrontiers in Medicine, 2018
- The journey of islet cell transplantation and future developmentIslets, 2018
- ERRγ Is Required for the Metabolic Maturation of Therapeutically Functional Glucose-Responsive β CellsCell Metabolism, 2016
- Generation of Functional Human Pancreatic β Cells In VitroCell, 2014
- Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in MiceDiabetes, 2012
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow CellsRadiation Research, 1961